Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
research and development
Biotech
GSK unveils cost-saving plan to fund R&D, move research HQ
GSK's three-year plan will divert resources to late-stage R&D and shift its research base—but CEO Luke Miels is tight-lipped about job losses.
James Waldron
Jul 28, 2026 9:50am
5 emerging biotech hubs
Jul 17, 2026 9:18am
AZ restarts £300M UK investment, but Merck not budging
Apr 29, 2026 10:01am
Takeda ends mRNA research pact with Japanese drug discoverer
Apr 14, 2026 9:57am
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
